MC1970A1 - Derives acyles - Google Patents

Derives acyles

Info

Publication number
MC1970A1
MC1970A1 MC882001A MC2001A MC1970A1 MC 1970 A1 MC1970 A1 MC 1970A1 MC 882001 A MC882001 A MC 882001A MC 2001 A MC2001 A MC 2001A MC 1970 A1 MC1970 A1 MC 1970A1
Authority
MC
Monaco
Prior art keywords
acyl derivatives
acyl
derivatives
Prior art date
Application number
MC882001A
Other languages
English (en)
French (fr)
Inventor
Gotschi Erwin
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1970A1 publication Critical patent/MC1970A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
MC882001A 1987-08-14 1988-08-11 Derives acyles MC1970A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH313387 1987-08-14
CH472687 1987-12-03

Publications (1)

Publication Number Publication Date
MC1970A1 true MC1970A1 (fr) 1989-09-29

Family

ID=25692275

Family Applications (1)

Application Number Title Priority Date Filing Date
MC882001A MC1970A1 (fr) 1987-08-14 1988-08-11 Derives acyles

Country Status (15)

Country Link
US (2) US5036064A (xx)
EP (1) EP0303172A3 (xx)
JP (1) JPS6466190A (xx)
KR (1) KR890003776A (xx)
AU (1) AU614984B2 (xx)
DK (1) DK455288A (xx)
FI (1) FI883766A (xx)
HU (1) HUT47944A (xx)
IL (1) IL87374A0 (xx)
MC (1) MC1970A1 (xx)
NO (1) NO883590L (xx)
NZ (1) NZ225754A (xx)
PH (1) PH25646A (xx)
PT (1) PT88274B (xx)
YU (1) YU156388A (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0366189A3 (en) * 1988-10-24 1992-01-02 Norwich Eaton Pharmaceuticals, Inc. Novel antimicrobial lactam-quinolones
US5030724A (en) * 1990-01-22 1991-07-09 E. R. Squibb & Sons, Inc. Monobactam hydrazides containing catechol sulfonic acid groups
US20040197408A1 (en) * 2002-12-30 2004-10-07 Angiotech International Ag Amino acids in micelle preparation
US7537532B2 (en) * 2007-05-16 2009-05-26 Young Carl D Handle for implement and method
KR101719556B1 (ko) * 2011-03-30 2017-03-24 주식회사 레고켐 바이오사이언스 신규한 세파로스포린 유도체 및 이를 함유하는 의약 조성물
WO2013036783A2 (en) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
US9290515B2 (en) 2011-10-04 2016-03-22 Shionogi & Co., Ltd Cephem derivative having catechol group
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
JP5681331B2 (ja) 2012-11-19 2015-03-04 三井化学株式会社 ポリエステル樹脂組成物とその製造方法
MX2020004205A (es) 2013-03-15 2021-11-16 Merck Sharp & Dohme Llc Composiciones antibioticas de ceftolozano.
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274991A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
EP3043797B1 (en) 2013-09-09 2020-04-08 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166115A (en) * 1976-04-12 1979-08-28 Fujisawa Pharmaceutical Co., Ltd. Syn 7-oxoimino substituted derivatives of cephalosporanic acid
GB1596278A (en) * 1976-11-30 1981-08-26 Glaxo Operations Ltd 7-(-oxyimino-acetamino)cephalosporin derivatives
DE150507T1 (de) * 1983-12-29 1987-02-26 Mochida Pharmaceutical Co., Ltd., Tokio/Tokyo, Jp Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate.
DE3687279T2 (de) * 1985-01-21 1993-05-13 Nippon Pharma Dev Inst Beta-lactam-antibiotika.
FI872879A (fi) * 1986-07-21 1988-01-22 Sankei Yakuhin Kk --laktamfoerening, foerfarande foer dess framstaellning, denna innehaollande laekemedelskomposition foer behandling av sjukdom med bakterieinfektion samt mellanprodukter foer dess syntes.
DE3840011A1 (de) * 1988-11-26 1990-05-31 Merck Patent Gmbh Benzoxazinderivate

Also Published As

Publication number Publication date
AU614984B2 (en) 1991-09-19
PH25646A (en) 1991-08-21
JPS6466190A (en) 1989-03-13
FI883766A (fi) 1989-02-15
EP0303172A2 (de) 1989-02-15
US5036064A (en) 1991-07-30
US5319140A (en) 1994-06-07
HUT47944A (en) 1989-04-28
DK455288A (da) 1989-02-15
EP0303172A3 (de) 1991-05-15
KR890003776A (ko) 1989-04-18
PT88274B (pt) 1995-03-01
NO883590L (no) 1989-02-15
YU156388A (en) 1990-02-28
AU2055488A (en) 1989-04-20
FI883766A0 (fi) 1988-08-12
DK455288D0 (da) 1988-08-12
PT88274A (pt) 1989-06-30
NZ225754A (en) 1991-04-26
IL87374A0 (en) 1989-01-31
NO883590D0 (no) 1988-08-12

Similar Documents

Publication Publication Date Title
MC1921A1 (fr) Derives acyles
MC1992A1 (fr) Derives de fluorocytidine
TR26815A (tr) Azolilmetil-sikropil türevleri
MC1879A1 (fr) Derives de la pyridazodiazepine
TR24894A (tr) N-FENILPIRAZOL TüREVLERI
MC1970A1 (fr) Derives acyles
DK507188D0 (da) Cholecalciferolderivater
FR2639044B1 (fr) Derives de la butynylamine
DK378088A (da) Alkenderivater
MC1916A1 (fr) Derives de propiolophenone
MC1920A1 (fr) Derives acyles
MC2000A1 (fr) Derives acyles
MC1422A1 (fr) Derives acyles
DK676188D0 (da) Propanamidderivater
DK271088A (da) Tienopyridinderivater
MC1962A1 (fr) Derives du benzimidazole
MC2108A1 (fr) Derives de quinoleine
DK695788D0 (da) Naphtalenderivater
MC1952A1 (fr) Derives acyles
DK733688A (da) Dioxazocinderivater
DK71488D0 (da) Dipenylethylen-derivater
FR2621590B1 (fr) Nouveaux derives du mercurobutol
MA20389A1 (fr) Derives de thiatriazines
DK313789A (da) Thiadiazinonderivater
DK474488D0 (da) Isoxazol-beta-carbolinderivater

Legal Events

Date Code Title Description
YP Annual fee paid